Craig Malzahn

Craig Malzahn is the Executive Vice President, Product Development and Chief Technology Officer at REGENXBIO. Mr. Malzahn has more than 30 years of experience in the biopharmaceutical industry. Prior to joining REGENXBIO in 2019, Mr. Malzahn served as Vice President and Site Head at GlaxoSmithKline (GSK). In that role, he led GSK’s commercial large-scale, drug substance biopharmaceutical site in Rockville, MD. Prior to GSK, Mr. Malzahn was Director of Supply Chain for Human Genome Sciences (HGS). Previous to HGS, Mr. Malzahn held several roles of increasing responsibility in vaccine manufacturing at Baxter and North American Vaccines. Mr. Malzahn earned his M.S. in Biotechnology from the Johns Hopkins University and B.S. in Biology from Virginia Tech.